$0.602
+0.023 (+3.88%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CTXR Prediction & Forecast by Similar Chart Analysis
Alphio's CTXR stock price prediction model matches the current Citius Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.60 (-0.33%). The 1-week path is $0.59 (-1.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Citius Pharmaceuticals Inc Stock?
Citius Pharmaceuticals Inc is a good buy right now due to its recent revenue growth of $7.1 million in Q3 2026, reflecting a significant market acceptance of its product LYMPHIR. Additionally, the gross margin for Q1 2026 was an impressive 79.99%, indicating strong profitability potential. However, the main risk is the net loss of $28.11 million reported in Q2 2026, which raises concerns about financial sustainability.
CTXR stock price ended at $0.60 on Thursday, after rising +3.88%
Citius Pharmaceuticals Inc (CTXR) last closed at $0.602, gaining +3.88%. These facts feed the 1-day and 1-week CTXR price prediction above.
Analyst Consensus
Citius Pharmaceuticals Inc (CTXR): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Citius Pharmaceuticals Inc (CTXR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CTXR, ranked by similarity.
Seasonality analysis for CTXR
Historically the probability of a positive September return for CTXR is 0.00%. April offers the highest probability of a positive month at 28.12%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.